How much funding has Vivodyne raised?

Vivodyne has raised $78.0M in total funding, most recently a series a round.

Who are Vivodyne's investors?

Vivodyne's investors include Khosla Ventures, Kairos Ventures, CS Ventures, Bison Ventures, MBX Capital, Lingotto.

Where is Vivodyne headquartered?

Vivodyne is headquartered in San Francisco Bay Area, California, United States.

What industry is Vivodyne in?

Vivodyne operates in Artificial Intelligence, Biotech, Healthcare.

Vivodyne

Human data before the clinic

San Francisco Bay Area, United States · Founded 2022 · $78.0M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: San Francisco Bay Area, California
Employees: 11–50
Founded: 2022
Business Model: B2B

Website: vivodyne.com
Total Funding: $78.0M
Last Round: $40.0M Series AMay 2025
Rounds: 2

About

Vivodyne is a biotechnology company that accelerates drug discovery by testing therapeutics on thousands of lab-grown human organ models using robotic automation and AI. Their proprietary Data Engine platform runs massive parallel studies on over 10,000 independent human tissues at a time, generating clinically predictive preclinical data without relying on animal testing. Vivodyne's multimodal AI integrates 3D phenomics, single-cell transcriptomics, and proteomics to identify new drug targets and optimize candidates before clinical trials.

Summary

Vivodyne is an Artificial Intelligence company based in San Francisco Bay Area, United States, founded in 2022. It has raised $78.0M in total across 2 rounds, most recently a $40.0M Series A round in May 2025. Investors include Khosla Ventures, Kairos Ventures and CS Ventures.

LinkedIn X (Twitter)